Dames S

Psychedelic-Assisted Therapy Graduate Certificate (PaTGC), Vancouver Island University (VIU), Nanaimo, British Columbia, Canada.

13 papers · ORCID

ArticlePsychedelics

Competencies and Ethical Governance for Psychedelic‑Assisted Therapies: A Practice‑Embedded Quality‑Improvement Framework.

Dames S, Williams K, Campbell A +5

Europe PMC2026
ArticlePsilocybin

Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis.

Tsang VW, Kryskow P, Watler C +2

Europe PMC2026
ArticleKetamine

Ketamine-Assisted Psychotherapy for Posttraumatic Stress Disorder: A Systematic Review and Individual Participant Data Meta-Analysis of Predictors of Treatment Effects.

Rohde J, Moore TM, Walker K +11

Europe PMC2026
ArticlePsilocybin

Improving access to psilocybin-assisted therapy: barriers, challenges, and recommendations.

Tsang VWL, Roney C, Kryskow P +1

Europe PMC2026
ArticlePsilocybin

Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.

Allen J, Sun M, Baker TL +5

Europe PMC2026
ArticleKetamine

A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the Roots To Thrive model.

Dames S, Kryskow P, Tsang VWL +1

Europe PMC2025
ArticleKetamine

Ketamine-assisted therapy within a community of practice: a novel approach to disordered eating.

Jeletzky L, Dames S, Kryskow P +1

Europe PMC2025
ArticlePsychedelics

Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence.

Dames S, Watler C, Kryskow P +4

Europe PMC2024
ArticlePsilocybin

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.

de la Salle S, Kettner H, Thibault Lévesque J +8

Europe PMC2024
ArticleKetamine

Indigenous Voices in Psychedelic Therapy: Experiential Learnings from a Community-Based Group Psychedelic Therapy Program.

Manson E, Ryding E, Taylor W +6

Europe PMC2023
ArticleKetamine

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.

Garel N, Drury J, Thibault Lévesque J +9

Europe PMC2023
ArticleKetamine

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review.

Tsang VWL, Tao B, Dames S +2

Europe PMC2023
ArticleKetamine

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression.

Dames S, Kryskow P, Watler C

Europe PMC2021